Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Bio-Rad Laboratories, Inc. (NYSE: BIO)
BIO Stock Predictions and Ratings
WSX Rating:
SELL
WSX Forecast (1yr):
-3.80%
Analyst Rating:
BUY
Analyst Forecast (1yr):
-45.90%
BIO Stock Analysis
BIO
PE Ratio:
52.5
BIO
PEG Ratio:
6.4
BIO
Forward EPS Growth (12 month):
8.20%
BIO
PS Ratio:
3.2
BIO
PSG Ratio:
1.2
BIO
Forward Revenue Growth (12 month):
2.60%
BIO Articles
No data was found